Registration is a 2-step process!
Select 'ENROLL NOW' to register and gain access to the link that will allow you to complete part 2 of the 2-step registration process.
Thursday, October 14, 2021 (1:00PM - 2:00PM EDT)
*Pre-registration is required to participate.
As COVID-19 infections surge once again, this wave brings a renewed focus on COVID-19 therapeutics, including both the medications being studied and approved therapies for prevention and treatment of COVID-19. Presenters will discuss the recently announced pharmacist authority to order and administer monoclonal antibody therapies and provide practical guidance on how pharmacists can become involved in administration of these therapies.
At the completion of this knowledge-based activity, participants will be able to:
- Discuss research methodology and how evidence is evaluated to support recommendations for use of COVID-19 therapeutics.
- Review the evidence base and debate on the use of ivermectin for the prevention and treatment of COVID-19.
- Discuss pharmacist authority to order and administer monoclonal antibody therapies and recommendations for their use to prevent and treat COVID-19.
- Describe pharmacy practice models that can be implemented to increase access to evidence-based monoclonal antibody therapies.
Activity type: Knowledge-based
Target Audience: Pharmacists
Learning Level: 2
The American Pharmacists Association is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. The following webinar is approved for 1.0 contact hours of CPE credit (0.1 CEUs). The ACPE Universal Activity Number for this activity is 0202-9999-21-370-L01-P.
To obtain credit for completing COVID-19 Therapeutics: Evidence-based Care and Practice Opportunities participants will need to complete the 2-step registration process, attend the live webinar, complete the evaluation questions, and then CLAIM credit. An attendance code and detailed instructions on how to claim credit will be provided during the webinar. Participants need to have a valid pharmacist.com username and password to claim credit. After credit has been claimed, please visit CPE monitor for your transcript.
Initial release date: October 14, 2021
Expiration date to claim credit for LIVE webinar: November 15, 2021 (11:59PM EDT)
Development and Support
COVID-19 Therapeutics: Evidence-based Care and Practice Opportunities is a live continuing education activity for pharmacists developed by the American Pharmacists Association. © 2021 American Pharmacists Association.
This project was funded in part by a collaborative agreement with the Centers for Disease Control and Prevention (CDC) —CoAgnumber 1 NU50CK000576-01-00. The CDC is an agency within the Department of Health and Human Services (HHS). Contents of this resource do not necessarily represent the CDC or HHS and should not be considered an endorsement by the Federal Government.
Disclosures will be presented day of webinar. APhA’s editorial staff declare no conflicts of interest or financial interests in any product or service mentioned in this activity, including grants, employment, gifts, stock holdings, and honoraria. For a complete list of APhA staff disclosures, visit the APhA website at www.pharmacist.com/apha-disclosures.
There is no fee associated with this activity. This learning product is conjunction with the APhA Open Forum Webinar series.
Computer and internet access are required to complete this activity. Please visit our website to view the Technology System Requirements in order to have a positive learning experience.
COVID-19 Therapeutics: Evidence-based Care and Practice Opportunities
|Date||10/14/2021 1:00:00 PM|
|Address||2215 Constitution Avenue NW|
|City||Washington||State||District of Columbia||Zip Code||20037|